Understanding healthcare providers’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States-Reference-Cited by-同舟云学术

Understanding healthcare providers’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States

Published:2024-04-02 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Mohanty Salini¹,Tsai Jui-Hua²,Ning Ning³,Martinez Ana²,Verma Rishi P.²,Heisen Marieke⁴,Weaver Jessica¹,Feemster Kristen A.¹,Chun Bianca¹,Weiss Thomas W.¹,Schmier Jordana K²

Affiliation:

1. Merck Research Laboratories, Merck & Co. Inc, Rahway, NJ, USA

2. Evidence & Access, OPEN Health, Bethesda, MD, USA

3. Evidence & Access, OPEN Health, Newton, MA, USA

4. Evidence & Access, OPEN Health, Rotterdam, The Netherlands

Funder

Merck Sharp & Dohme LLC

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2325745

Reference22 articles.

1. Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance

2. Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines

3. Centers for Disease Control and Prevention. Surveillance and reporting; 2020 Sep 1 [accessed 2023 Jan 5]. https://www.cdc.gov/pneumococcal/surveillance.html.

4. Centers for Disease Control and Prevention. Global Pneumococcal disease and vaccination; 2022 Jan 27 [accessed 2023 Jan 5]. https://www.cdc.gov/pneumococcal/global.html.

5. Gierke R. Current epidemiology of pediatric pneumococcal disease United States. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-02/slides-02-22/Pneumococcal-02-Gierke-508.pdf.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Pneumococcal Conjugate Vaccine and Dosing Schedule Perceptions Among Health Care Providers and Caregivers in Germany, France, Spain, and Greece;Infectious Diseases and Therapy;2024-07-26